Wolverine Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Wolverine Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-200	Closed	-$7K	–	1699
2025 Q3	$7K	Hold	200	–	–	﹤0.01%	1406
2025 Q2	$5.91K	Hold	200	–	–	﹤0.01%	1425
2025 Q1	$5.97K	Hold	200	–	–	﹤0.01%	1357
2024 Q4	$5.73K	Sell	200 -11,100	-98%	-$367K	﹤0.01%	1406
2024 Q3	$437K	Buy	11,300 +1,000	+10%	+$35.7K	﹤0.01%	893
2024 Q2	$332K	Hold	10,300	–	–	﹤0.01%	913
2024 Q1	$400K	Sell	10,300 -35,800	-78%	-$1.25M	﹤0.01%	859
2023 Q4	$1.42M	Buy	46,100 +4,400	+11%	+$110K	0.01%	609
2023 Q3	$932K	Sell	41,700 -2,300	-5%	-$52.5K	0.01%	729
2023 Q2	$946K	Buy	+44,000	New	+$999K	0.01%	698

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Asset Management's COLL Position: Q2 2025 in Review

Wolverine Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2025, closing a stake of 18,864 shares — an estimated $538K sold.

Wolverine Asset Management first reported a position in COLL in Q3 2022 and held it in 3 quarters. The position peaked at $563K in Q1 2025. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

Wolverine Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Wolverine Asset Management sold 18,864 Collegium Pharmaceutical shares in Q2 2025, an estimated $538K.
Wolverine Asset Management first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 3 quarters.
Wolverine Asset Management's Collegium Pharmaceutical position peaked at $563K in Q1 2025.
223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on Wolverine Asset Management's 13F filing for Q2 2025, filed 4 Aug 2025.